Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Plants and seeds of corn variety CV092363
Method and a channel estimating arrangement for performing channel estimation
System, method, and computer program product for identifying unwanted data communicated via a session initiation protocol
Liquid crystal display
Hydrating lounge chair
Transmission apparatus, receiving apparatus, method, and storage medium
Identification of biomarkers in biological samples and methods of using same
  Randomly Featured Patents
Electrotransport delivery device
Hydride bed water recovery system for a fuel cell power plant
Electrical connector with reduced crosstalk for high frequency signals
High-speed serial data transmitter architecture
Phase change ink transfix pressure component with dual-layer configuration
Artificial hip joint
Initialisation of a pipelined processor
Methods and systems for determining a set of costs of routes in a network
Exercise apparatus